Advanced Medical Isotope Corporation (OTCMKTS:RDGL – Get Free Report) saw a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 3,748 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 2,270,533 shares, the short-interest ratio is presently 0.0 days.
Advanced Medical Isotope Stock Down 2.0%
Shares of RDGL stock opened at $0.04 on Friday. The stock has a market cap of $22.14 million, a P/E ratio of -4.48 and a beta of -0.56. Advanced Medical Isotope has a fifty-two week low of $0.04 and a fifty-two week high of $0.12. The business has a fifty day simple moving average of $0.05 and a 200-day simple moving average of $0.06.
Advanced Medical Isotope Company Profile
Advanced Medical Isotope Corp. (OTCMKTS:RDGL) is a medical technology company developing isotope-based treatments for cancer and other localized medical conditions. Its work centers on targeted radiation therapies designed to deliver radioactive material directly to tumors while limiting exposure to surrounding healthy tissue.
The company’s principal product platform is Radiogel, an injectable, biodegradable gel intended to deliver therapeutic radioisotopes locally within solid tumors.
Further Reading
- Five stocks we like better than Advanced Medical Isotope
- MarketBeat Week in Review – 10/26 – 10/30
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.
